These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 21934492)

  • 1. Band-shaped keratopathy in Chinese patients with Vogt-Koyanagi-Harada syndrome.
    Yang P; Sun M
    Cornea; 2011 Dec; 30(12):1336-40. PubMed ID: 21934492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic regimen in Vogt-Koyanagi-Harada syndrome].
    Yang P; Wang H; Zhou H; Zhong H; Li F; Huang X; Zhong H; Fu T
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):196-9. PubMed ID: 12133384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vogt-Koyanagi-Harada disease in Thailand.
    Yodmuang T; Rothova A; Kunavisarut P; Pathanapitoon K
    Ocul Immunol Inflamm; 2012 Dec; 20(6):419-22. PubMed ID: 23163754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for poor visual outcome following cataract surgery in Vogt-Koyanagi-Harada disease.
    Quek DT; Jap A; Chee SP
    Br J Ophthalmol; 2011 Nov; 95(11):1542-6. PubMed ID: 21349937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vogt-Koyanagi-Harada disease in children.
    Abu El-Asrar AM; Al-Kharashi AS; Aldibhi H; Al-Fraykh H; Kangave D
    Eye (Lond); 2008 Sep; 22(9):1124-31. PubMed ID: 17479116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
    Yang P; Ren Y; Li B; Fang W; Meng Q; Kijlstra A
    Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical manifestations and diagnosis of Vogt-Koyanagi-Harada syndrome].
    Yang P; Wang H; Zhou H; Huang X; Zhong H; Chen L; Zhong H; Fu T
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):736-9. PubMed ID: 12654224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease.
    Vukojević M; Vukojevic N; Vuković A; Rupčić B; Blažević M; Blažević A
    Acta Dermatovenerol Croat; 2023 Dec; 31(4):229-231. PubMed ID: 38651852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vogt-Koyanagi-Harada disease: clinical outcomes.
    Bykhovskaya I; Thorne JE; Kempen JH; Dunn JP; Jabs DA
    Am J Ophthalmol; 2005 Oct; 140(4):674-8. PubMed ID: 16226518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal quantification of aqueous flare and cells in Vogt-Koyanagi-Harada disease.
    Fang W; Zhou H; Yang P; Huang X; Wang L; Kijlstra A
    Br J Ophthalmol; 2008 Feb; 92(2):182-5. PubMed ID: 17965105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship of Vogt-Koyanagi-Harada Syndrome to Ocular Hypertension and Glaucoma.
    Veerappan M; Fleischman D; Ulrich JN; Stinnett SS; Jaffe GJ; Allingham RR
    Ocul Immunol Inflamm; 2017 Dec; 25(6):748-752. PubMed ID: 27438521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD; Rathinam SR; Cunningham ET
    Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optic disc swelling in Vogt-Koyanagi-Harada disease.
    Nakao K; Abematsu N; Mizushima Y; Sakamoto T
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1917-22. PubMed ID: 22408010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vogt-Koyanagi-Harada syndrome: importance of rapid diagnosis and therapeutic intervention].
    Bouchenaki N; Morisod L; Herbort CP
    Klin Monbl Augenheilkd; 2000 May; 216(5):290-4. PubMed ID: 10863695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and Prognostic Factors of Phacoemulsification Cataract Surgery in Vogt-Koyanagi-Harada Uveitis.
    Ji Y; Hu K; Li C; Li P; Kijlstra A; Eghrari AO; Lei B; Du L; Wan W; Yang P
    Am J Ophthalmol; 2018 Dec; 196():121-128. PubMed ID: 30194930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, Risk Factors and Surgical Outcomes of Cataract among Patients with Vogt-Koyanagi-Harada Disease.
    AlBloushi AF; Alfawaz AM; AlZaid A; Alsalamah AK; Gikandi PW; Abu El-Asrar AM
    Ocul Immunol Inflamm; 2021 Jan; 29(1):128-136. PubMed ID: 31638886
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore.
    Chee SP; Jap A; Bacsal K
    Am J Ophthalmol; 2009 Jan; 147(1):154-161.e1. PubMed ID: 18834575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis].
    Zhang M; Liu Q; Min H; Du H; Hu T
    Zhonghua Yan Ke Za Zhi; 2002 Apr; 38(4):200-3. PubMed ID: 12133385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.
    Yang P; Liu X; Zhou H; Guo W; Zhou C; Kijlstra A
    Clin Exp Ophthalmol; 2011; 39(7):639-47. PubMed ID: 22452682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.